Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes

Prognostic Impact of Platelet-Large Cell Ratio In Myelodysplastic Syndromes

BackgroundMyelodysplastic syndromes (MDSs) are a very heterogeneous group of myeloid disorders with high prevalence and risk of developing acute myeloid leukemia. The more accurate risk stratification can provide a better guidance of treatment. The platelet–large cell ratio (P-LCR) is a parameter re...

Full description

Bibliographic Details
Main Authors: Qiuni Chen, Yue Chen, Yijing Zhang, Lijuan Zhang, Kankan Chen, Zhengmei He, Chunling Wang, Liang Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
myelodysplastic syndromes (MDS)
platelet–large cell ratio (P-LCR)
survival
prognosis
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.846044/full

Similar Items

Similar Items